drugset / Trial / NCT02735473
Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders
Phase 2
Completed
46 enrolled
University of Minnesota
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized, double-blind, placebo-controlled trial of choline supplementation in children with Fetal Alcohol Spectrum Disorders (FASD). The primary outcome measures are cognitive measures.
Timeline
- Start
- 2016-06
- Primary completion
- 2021-09-10
- Completion
- 2021-09-10
Outcome
Met primary endpoint
paper participants receiving choline performed 25% better on EI short-delay adjacent pairs (sequential memory) than those on placebo PMID 39956364 ↗
paper with a steeper increase in scores between 6 and 9 mo (ŷ = -10.06; P = 0.03; 95% CI: -19.13, -0.99). PMID 39956364 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Choline Bitartrate | Small molecule | 19 mg/kg | — |